Kimberly K. Scarsi - Concepedia

Author

Kimberly K. Scarsi

University of Nebraska Medical Center ORCID

Also Known As

Hudgens, Michael G., Jomy George, K Scarsi, K. K. Scarsi, K. Scarsi, K.K. Scarsi, KK Scarsi, Kimberly K Scarsi, Kimberly K. Scarsi, Kimberly Scarsi

134

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

University of Nebraska Medical Center Northwestern University Nebraska Medical Center Northwestern Memorial Hospital University of California, San Francisco

About

Kimberly K. Scarsi is an author at University of Nebraska Medical Center specializing in medicine, hiv, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	424
2	Public Health	4	4	165
3	Emergency Medicine	2	2	86
4	Health Sciences	1	1	54
5	Biomedical Engineering	1	1	15

Kimberly K. Scarsi

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Pharmacist participation in medical rounds reduces medication errors Kimberly K. Scarsi, Michael A. Fotis, Gary A. Noskin American Journal of Health-System Pharmacy Population Health SciencesPharmacotherapyNorthwestern Memorial HospitalPharmacodynamic ModelingPre-clinical Pharmacology	2002	140
Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study Catherine A. Chappell, Kimberly K. Scarsi, Brian Kirby, The Lancet Microbe	2020	109
Acceptability and Feasibility of a Pharmacist-Led Human Immunodeficiency Virus Pre-Exposure Prophylaxis Program in the Midwestern United States Joshua P Havens, Kimberly K. Scarsi, Harlan Sayles, Open Forum Infectious Diseases	2019	99
Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks Kimberly K. Scarsi, Kristin M. Darin, Shadia Nakalema, Clinical Infectious Diseases	2015	87
Minocycline treatment for HIV-associated cognitive impairment Ned Sacktor, Sachiko Miyahara, Lijuan Deng, Neurology	2011	86
Pharmacist-provided rapid HIV testing in two community pharmacies Kristin M. Darin, Michael E. Klepser, Donald E. Klepser, Journal of the American Pharmacists Association Sexual HealthCommunity PharmaciesHiv/aids CounsellingTreatment And PreventionDrug Testing	2014	86
Plasma and intracellular pharmacokinetics of tenofovir in patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide Anthony T. Podany, Sara H Bares, Joshua P Havens, AIDS	2018	83
Adherence and Viral Suppression Among Participants of the Patient-centered Human Immunodeficiency Virus (HIV) Care Model Project: A Collaboration Between Community-based Pharmacists and HIV Clinical Providers Kathy K. Byrd, John Hou, Tim Bush, Clinical Infectious Diseases	2019	56
Impact of Inactive Empiric Antimicrobial Therapy on Inpatient Mortality and Length of Stay Kimberly K. Scarsi, Joe Feinglass, Marc H. Scheetz, Antimicrobial Agents and Chemotherapy Inpatient MortalityEscherichia ColiDrug ResistanceHospital MedicineInactive Empiric Therapy	2006	54
Efavirenz decreases etonogestrel exposure Catherine A. Chappell, Mohammed Lamorde, Shadia Nakalema, AIDS	2017	43

Page 1